PTAB extends an IPR for good cause for the first time
The PTAB has extended the one-year deadline in Minerva Surgical v Hologic by six months. The final written decision in the inter partes review was originally set to expire two days after the Federal Circuit released its en banc Aqua Products opinion
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
